Clinical features and prognosis of drug-induced liver injury in patients with non-alcoholic fatty liver

doi:10.4254/wjh.v17.i2.101741

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1204)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-14) series.

Item

Count

PDF

HTML

732

Figures (1-2)

132

Tables (1-14)

136

Sum=1025

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

113

Sum=125

Feb 27, 2025 (publication date) through Apr 24, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Feb 27, 2025; 17(2): 101741
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.101741

Table 11 Analysis of steroid usage in the two groups

	DILI (n = 89)	DILI + NAFL (n = 110)	P value
Hormone use (number)	13 (14.6)	12 (10.9)	0.434

DILI: Drug-induced liver injury; NAFL: Nonalcoholic fatty liver.

Citation: Zhao Y, Li JZ, Liu YG, Zhu YJ, Zhang Y, Zheng WW, Ma L, Li J, Wang CY. Clinical features and prognosis of drug-induced liver injury in patients with non-alcoholic fatty liver. World J Hepatol 2025; 17(2): 101741
URL: https://www.wjgnet.com/1948-5182/full/v17/i2/101741.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i2.101741